Pazopanib Impurity 18 |
|
|---|---|
| CAT. No : | P1070062 |
| CAS. No : | 1072836-76-0 |
| Mol. F : | C14H17N3O4S2 |
| Mol. Wt : | 355.43 g/mol |
| Synonyms : | Benzenesulfonamide,5-amino-N-((5-amino-2-methylphenyl)sulfonyl)-2-methyl;5-Amino-N-((5-amino-2-methylphenyl)sulfonyl)-2-methylbenzenesulfonamide |
| Chemical Name : | 1-(2,3-Dichlorophenyl)-4-(2-((1r,4r)-4-(3,3-dimethylureido)cyclohexyl)ethyl)piperazine 1,4-dioxide |
| Stock Status : | Custom Synthesis |
- Smiles:O=S(C1=CC(N)=CC=C1C)(NS(=O)(C2=CC(N)=CC=C2C)=O)=O
- Buy High-Quality Pazopanib Impurity 18 from Simson Pharma Limited at best competitive price.
- Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Product Applications & Regulatory Search Terms:
Buy 1072836-76-0 | Purchase 1072836-76-0 | Order 1072836-76-0 | Enquire 1072836-76-0 | Price of 1072836-76-0 | 1072836-76-0 Supplier | 1072836-76-0 Manufacturer | 1072836-76-0 Exporter | Pazopanib Impurity 18 for Method Validation | Pazopanib Impurity 18 Reference Standard | Pazopanib Impurity 18 for ANDA Filing | Pazopanib Impurity 18 for Forced Degradation Studies | Pazopanib Impurity 18 Identification Standards | Pazopanib Impurity 18 for DMF Filing | Buy high quality Pazopanib Impurity 18 | Purchase Pazopanib Impurity 18 | Pazopanib Impurity 18 suppliers | Pazopanib Impurity 18 manufacturers | Pazopanib Impurity 18 price | Pazopanib Impurity 18 exporter | Order Pazopanib Impurity 18 | Enquire Pazopanib Impurity 18 | Pazopanib Impurity 18 cost | Pazopanib Impurity 18 Supplier | Pazopanib Impurity 18 Distributor
Disclaimer:
The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.
This product is intended for research use only and is not approved for human consumption.
